Atria Investments LLC Sarepta Therapeutics, Inc. Transaction History

Atria Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $251,252 - $363,255	2,217 New	2,217 $350,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $436,778 - $697,955	-5,302 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $143,876 - $254,890	1,880 Added 54.94%	5,302 $684,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $57,738 - $124,429	793 Added 30.16%	3,422 $258,000
Q2 2019 Aug 26, 2019	BUY	$112.21 - $151.95 $295,000 - $399,476	2,629 New	2,629 $327,000
Q2 2019 Aug 09, 2019	SELL	$112.21 - $151.95 $324,174 - $438,983	-2,889 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $102,723 - $146,067	963 Added 50.0%	2,889 $344,000
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $25,497 - $38,975	262 Added 15.75%	1,926 $210,000
Q3 2018 Oct 09, 2018	BUY	$115.31 - $161.51 $191,875 - $268,752	1,664 New	1,664 $269,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Atria Investments LLC with notifications on news.